Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

AKTX

Akari Therapeutics, Plc

Healthcare · USD

Set alert

Price alert · AKTX

All alert types
8.24 USD +0.24 +3.00%
As of Oct 30, 2026 Extended hours 8.00 -2.91%
Bid
8.00 × 7
Ask
8.25 × 14
8.07 Day range 8.95
3.06 52-week range 32.80
YTD
-28.72%
1 year
-71.78%
Open
8.50
Prev close
8.00
Mkt cap
18.83M
Vol
45.80K
Avg vol
62.34K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
8.07
High
8.95
Forward P/E
-0.29
Beta
0.95
Short ratio
1.92
Inst. own
0.51%
Dividend
0.00
Ex-div date
Earnings
May 6, 2024
50-d avg
1.78
200-d avg
2.41
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m
AKTX five-day price chart7.648.198.739.289.83Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-12.62 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -0.0×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.0×
FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.3×FY 2023: -1.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/FCF -0.0×
FY 2016: -0.1×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.1×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
EV/EBITDA 0.2×
FY 2016: 1.2×FY 2017: 0.8×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.7×FY 2021: 0.5×FY 2022: 0.7×FY 2023: 0.4×FY 2024: -0.0×FY 2025: 0.2×
FY 2016 5y median 0.4× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -4345.0%
FY 2016: -1934.6%FY 2017: -3058.7%FY 2018: -4660.4%FY 2019: -2016.9%FY 2020: -2682.2%FY 2021: -1463.7%FY 2022: -3664.9%FY 2023: -5380.7%FY 2024: -4307.0%FY 2025: -4345.0%
FY 2016 5y median -4307.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -61.1%
FY 2016: -53.2%FY 2017: -139.8%FY 2018: -149.1%FY 2019: -439.2%FY 2020: -182.0%FY 2021: -313.7%FY 2022: -991.0%FY 2023: 4370.3%FY 2024: -89.0%FY 2025: -61.1%
FY 2016 5y median -89.0% FY 2025
ROIC -45.0%
FY 2016: -79.6%FY 2017: -149.6%FY 2018: -126.9%FY 2019: -348.9%FY 2020: -191.6%FY 2021: -309.9%FY 2022: -1289.1%FY 2023: 7338.9%FY 2024: -63.8%FY 2025: -45.0%
FY 2016 5y median -63.8% FY 2025
ROA -36.1%
FY 2016: -39.5%FY 2017: -96.1%FY 2018: -121.3%FY 2019: -163.4%FY 2020: -117.0%FY 2021: -149.6%FY 2022: -128.3%FY 2023: -229.8%FY 2024: -39.1%FY 2025: -36.1%
FY 2016 5y median -128.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 20.2%
FY 2016: 10.9%FY 2017: -28.3%FY 2018: 42.8%FY 2019: -24.4%FY 2020: 27.7%FY 2021: 4.3%FY 2022: -34.1%FY 2023: 27.2%FY 2024: -28.8%FY 2025: 20.2%
FY 2016 FY 2025
EPS (diluted) 84.3%
FY 2016: 62.4%FY 2017: -50.0%FY 2018: 55.6%FY 2019: 30.9%FY 2020: 39.1%FY 2021: 27.5%FY 2022: 29.9%FY 2023: 64.1%FY 2024: 18.6%FY 2025: 84.3%
FY 2016 FY 2025
Free Cash Flow 15.8%
FY 2016: -396.0%FY 2017: -28.2%FY 2018: 28.8%FY 2019: 42.7%FY 2020: -31.2%FY 2021: -11.2%FY 2022: -14.1%FY 2023: 23.6%FY 2024: 23.6%FY 2025: 15.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.4×
FY 2016: 3.9×FY 2017: 3.2×FY 2018: 5.3×FY 2019: 1.9×FY 2020: 2.8×FY 2021: 1.9×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.1×FY 2025: 0.4×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 0.4×
FY 2016: 3.9×FY 2017: 3.2×FY 2018: 6.0×FY 2019: 2.1×FY 2020: 2.8×FY 2021: 1.9×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.1×FY 2025: 0.4×
FY 2016 5y median 0.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 1.3×FY 2017: 0.8×FY 2018: 0.4×FY 2019: 0.2×FY 2020: 0.8×FY 2021: 0.5×FY 2022: 0.7×FY 2023: 0.4×FY 2024: -0.0×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -18.2×
FY 2016: -3.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 88.7×FY 2025: -18.2×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31